Search

everythinglearnresearchcommunity

for

Search:↓

Men prefer less invasive cosmetic procedures and need different treatment approaches than women.

Hair loss can cause emotional and social issues, and various treatments, including medication, surgery, and psychological support, are needed.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

People with androgenetic alopecia have more personality disorders and mental health symptoms; treatment may help.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Some African American women experience central scalp hair loss, often linked to a history of fungal scalp infection.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Dermatologists perform most outpatient cosmetic procedures in the U.S., especially on white women aged 40 to 59.

Women with hair loss had lower IGF-1 levels.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

Right hand finger ratio may predict male hair loss.

Seborrheic dermatitis may contribute to the development of central centrifugal cicatricial alopecia.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Laser treatment effectively increases hair density and thickness in androgenic alopecia.

Minoxidil can treat hair loss with topical, oral, and sublingual options, offering personalized choices.

Shorter, thinner hairs indicate AGA, while longer, thicker hairs suggest CTE; counting and measuring shed hairs helps diagnose hair loss type.

Horizontal sections of scalp biopsies are good for diagnosing Central Centrifugal Cicatricial Alopecia and help customize treatment.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

Androgenetic alopecia patients often experience higher rates of depression and anxiety, suggesting mental health screening before finasteride treatment.

Photobiomodulation therapy significantly increases hair density and growth for androgenic alopecia, but more research is needed to confirm safety.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Dermatologists performed the most outpatient cosmetic procedures in the U.S. from 1995 to 2003, especially on white women aged 40 to 59.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Wearing a cap doesn't affect quality of life for Indian men with hair loss, but severe hair loss does lower it. Older men have more severe hair loss, and those who wear caps more often want less treatment.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.